Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pressure Biosciences Inc (OP: PBIO )

0.0031 UNCHANGED
Streaming Delayed Price Updated: 12:23 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pressure Biosciences Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters New Contract Expected to Generate Significant 2023 Revenue, Drive Accelerated Future Growth
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform
PBI Partners with Leading Colorado Cannabis Company for Manufacture and Distribution of Novel Nano-CBD Topical Spray and Other Products, Anticipating $2 Million in 2023 Revenue Contribution 
From Pressure BioSciences Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Emerging Growth Conference
Via Investor Brand Network
Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference - Annual Revenue to PBI Expected to Exceed $1M
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Update/Q&A Session 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at 34th Emerging Growth Conference
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation in Upcoming Webinar Focused on Revolutionizing Development of Plant-Based Food Products
Via Investor Brand Network
Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products
Investors, Analysts, and Advisors Invited to Attend this Real-Time, Interactive Presentation/Q&A Event 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters ‘Pivotal’ Agreement for Nanoemulsified CBD Spray for Oral Use
Via Investor Brand Network
Pressure BioSciences Announces Contracted Production Launch for Estimated $3,000,000 of UST-Processed, Nanoemulsified CBD Spray for Oral Use
Safer Medical of Montana, a Seasoned Distributor of Wellness Products with a Focus on Veterans, Partners with PBI as Exclusive Distributor for Highly Stable and Water-Soluble CBD Oral Aerosol Product 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Potential of UST(TM) as ‘Essential Tool in Future Beverage Development’
Via Investor Brand Network
Global Plant Based Protein Market Expected To Reach $40 Billion by 2027
Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – The pandemic has considerably transformed consumer buying patterns, with a steady shift being witnessed toward health-improving... 
Via FinancialNewsMedia
Pressure BioSciences’ Ultra Shear Technology™ Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market
Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI’s UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages South... 
Via FinancialNewsMedia
Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market
Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI's UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses UST(TM) Platform, Early Access Program on Stock Day Podcast
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences Discusses Launch of Early Access Program for Ultra Shear Technology for the Processing of Nanoemulsions with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - June 1, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI"... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured in New ‘TechTalks’ Video
Via Investor Brand Network
Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences' CEO Richard T. Schumacher
SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that Emerging Technology Insider, a leading global source for business... 
From Pressure BioSciences Inc.
Via AccessWire
Pressure BioSciences, Inc. Reports Q1 2022 Financial Results
Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential Customers for Nanoemulsion Processing in Nutraceuticals and... 
From Pressure BioSciences Inc.
Via AccessWire
Topics Economy
Exposures COVID-19 Supply Chain
Pressure BioSciences Signs Multi-Year Manufacturing Agreement; To Be First Product Commercially Sold Into Consumer Market Containing UST-Produced Nanoemulsion
Image sourced from Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases First-Quarter 2022 Financial Report, Corporate Update
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters First UST Early Access Manufacturing Agreement
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program
Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD Topical Spray for Pain Reduction 
Via Benzinga
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Pressure BioSciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate at Upcoming Planet MicroCap Showcase
Via Investor Brand Network
Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Pressure BioSciences Inc.
Via AccessWire
SRAX (NASDAQ: SRAX) Releases Replays From 2022 Cannabis And Psychedelic Conference
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Early Access Program for Use of Its Revolutionary UST(TM) Platform
Via Investor Brand Network
Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing
Strong Market Demand Fuels Company's Decision to Access Early Revenue Generating Opportunities for UST Processing of High Quality Nanoemulsions of Oil-Based Active Ingredients for Multiple Markets... 
From Pressure BioSciences Inc.
Via AccessWire
InvestorNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Availability of Replays from the 2022 Sequire Cannabis and Psychedelic Conference
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.